BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29698802)

  • 21. Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma.
    Papale M; Vocino G; Lucarelli G; Rutigliano M; Gigante M; Rocchetti MT; Pesce F; Sanguedolce F; Bufo P; Battaglia M; Stallone G; Grandaliano G; Carrieri G; Gesualdo L; Ranieri E
    Oncotarget; 2017 Jun; 8(25):40412-40424. PubMed ID: 28418894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percentage grade 4 tumour predicts outcome for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Varma M; Samaratunga H
    Pathology; 2019 Jun; 51(4):349-352. PubMed ID: 30987774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry.
    Smith A; Iablokov V; Mazza M; Guarnerio S; Denti V; Ivanova M; Stella M; Piga I; Chinello C; Heijs B; van Veelen PA; Benediktsson H; Muruve DA; Magni F
    Kidney Blood Press Res; 2020; 45(2):233-248. PubMed ID: 32062660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma.
    Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T
    J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. iTRAQ-based quantitative proteomic analysis reveals potential early diagnostic markers of clear-cell Renal cell carcinoma.
    Zhang L; Jiang H; Xu G; Chu N; Xu N; Wen H; Gu B; Liu J; Mao S; Na R; Jing Y; Ding Q; Zhang Y; Wang L
    Biosci Trends; 2016 Jul; 10(3):210-9. PubMed ID: 27319973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Searching for prognostic biomarkers for small renal masses in the urinary proteome.
    Di Meo A; Batruch I; Brown MD; Yang C; Finelli A; Jewett MA; Diamandis EP; Yousef GM
    Int J Cancer; 2020 Apr; 146(8):2315-2325. PubMed ID: 31465112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
    Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
    Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of tumour-associated necrosis provides prognostic information additional to World Health Organization/International Society of Urological Pathology grading for clear cell renal cell carcinoma.
    Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Coughlin G; Dunglison N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Samaratunga H
    Histopathology; 2019 Jan; 74(2):284-290. PubMed ID: 30129659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Label-free quantitative proteomic analysis reveals potential biomarkers and pathways in renal cell carcinoma.
    Zhao Z; Wu F; Ding S; Sun L; Liu Z; Ding K; Lu J
    Tumour Biol; 2015 Feb; 36(2):939-51. PubMed ID: 25315187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MALDI Orbitrap Mass Spectrometry Profiling of Dysregulated Sulfoglycosphingolipids in Renal Cell Carcinoma Tissues.
    Jirásko R; Holčapek M; Khalikova M; Vrána D; Študent V; Prouzová Z; Melichar B
    J Am Soc Mass Spectrom; 2017 Aug; 28(8):1562-1574. PubMed ID: 28361385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathway analysis of kidney cancer using proteomics and metabolic profiling.
    Perroud B; Lee J; Valkova N; Dhirapong A; Lin PY; Fiehn O; Kültz D; Weiss RH
    Mol Cancer; 2006 Nov; 5():64. PubMed ID: 17123452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype.
    Steurer S; Seddiqi AS; Singer JM; Bahar AS; Eichelberg C; Rink M; Dahlem R; Huland H; Sauter G; Simon R; Minner S; Burandt E; Stahl PR; Schlomm T; Wurlitzer M; Schlüter H
    Anticancer Res; 2014 May; 34(5):2255-61. PubMed ID: 24778028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis.
    Yang J; Li A; Yang Y; Li X
    Cancer Biol Ther; 2011 Mar; 11(5):535-46. PubMed ID: 21368578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominantly cystic clear cell renal cell carcinoma and multilocular cystic renal neoplasm of low malignant potential form a low-grade spectrum.
    Tretiakova M; Mehta V; Kocherginsky M; Minor A; Shen SS; Sirintrapun SJ; Yao JL; Alvarado-Cabrero I; Antic T; Eggener SE; Picken MM; Paner GP
    Virchows Arch; 2018 Jul; 473(1):85-93. PubMed ID: 29770853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.
    Erlmeier F; Sun N; Shen J; Feuchtinger A; Buck A; Prade VM; Kunzke T; Schraml P; Moch H; Autenrieth M; Weichert W; Hartmann A; Walch A
    Oncology; 2023; 101(2):126-133. PubMed ID: 36198279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The highest Fuhrman and WHO/ISUP grade influences the Ki-67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma.
    Murase Y; Iwata H; Takahara T; Tsuzuki T
    Pathol Int; 2020 Dec; 70(12):984-991. PubMed ID: 32997867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambient ionization mass spectrometric analysis of human surgical specimens to distinguish renal cell carcinoma from healthy renal tissue.
    Alfaro CM; Jarmusch AK; Pirro V; Kerian KS; Masterson TA; Cheng L; Cooks RG
    Anal Bioanal Chem; 2016 Aug; 408(20):5407-14. PubMed ID: 27206411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated clear cell renal carcinoma grade classification with prognostic significance.
    Tian K; Rubadue CA; Lin DI; Veta M; Pyle ME; Irshad H; Heng YJ
    PLoS One; 2019; 14(10):e0222641. PubMed ID: 31581201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of clear cell renal cell carcinoma by gene expression profiling.
    Thibodeau BJ; Fulton M; Fortier LE; Geddes TJ; Pruetz BL; Ahmed S; Banes-Berceli A; Zhang PL; Wilson GD; Hafron J
    Urol Oncol; 2016 Apr; 34(4):168.e1-9. PubMed ID: 26670202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.